The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to
reflect latest evidence.For further information, see below:Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19
Updated recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19
Published in All WHO news
More from All WHO newsMore posts in All WHO news »
- Third meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
- Nearly 50 million people sign up call for clean air action for better health
- UN Commission approves WHO recommendations to place psychoactive substances under international control
- Frank, in-depth discussion as Belgium and WHO map ahead priorities for collaboration